Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia

Schizophrenia Research

Volumn 166, Issue 1-3, 2014, Pages 212-218

  Matosin, Natalie ^a,b   Fernandez Enright, Francesca ^a,b   Lum, Jeremy S ^a,b   Andrews, Jessica L ^a,b   Engel, Martin ^a,b   Huang, Xu Feng ^a,b   Newell, Kelly A ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Hippocampus; mGluR5; Norbin; Schizophrenia; Tamalin; Trafficking

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; METABOTROPIC RECEPTOR 5; NORBIN; OLANZAPINE; REGULATOR PROTEIN; TAMALIN; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; CARRIER PROTEIN; GRASP PROTEIN, HUMAN; GRM5 PROTEIN, HUMAN; GRM5 PROTEIN, RAT; GRP1-ASSOCIATED SCAFFOLD PROTEIN, RAT; MEMBRANE PROTEIN; NERVE PROTEIN; NEUROLEPTIC AGENT; NEUROPEPTIDE; NORBIN PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN TISSUE; LIFESPAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHIZOPHRENIA; ANIMAL; DIMERIZATION; DRUG EFFECTS; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CA1 REGION, HIPPOCAMPAL; CARRIER PROTEINS; CHLORPROMAZINE; DIMERIZATION; FEMALE; HALOPERIDOL; HUMANS; IMMUNOBLOTTING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPEPTIDES; RATS, SPRAGUE-DAWLEY; RECEPTOR, METABOTROPIC GLUTAMATE 5; SCHIZOPHRENIA;

EID: 84955176919     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.05.001     Document Type: Article

References (30)

1. Ayala, J.E., Chen, Y., Banko, J.L., Sheffler, D.J., Williams, R., Telk, A.N., Watson, N.L., Xiang, Z., Zhang, Y., Jones, P.J., Lindsley, C.W., Olive, M.F., Conn, P.J., 2009. mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology 34 (9), 2057-2071.
2. Benes, F.M., Todtenkopf, M.S., Kostoulakos, P., 2001. GluR5, 6, 7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11 (5), 482-491.
3. Brakeman, P.R., Lanahan, A.A., O'Brien, R., Roche, K., Barnes, C.A., Huganir, R.L., Worley, P.F., 1997. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386 (6622), 284-288.
4. Breese, C.R., Freedman, R., Leonard, S.S., 1995. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674 (1), 82-90.
5. Eastwood, S.L., McDonald, B., Burnet, P.W., Beckwith, J.P., Kerwin, R.W., Harrison, P.J., 1995. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluRl and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29 (2), 211-223.
6. Eastwood, S.L., Kerwin, R.W., Harrison, P.J., 1997. Immunoautoradiographic evidence for a loss of a-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-Nmethyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry 41 (6), 636-643.
7. Engmann, O., Hortobágyi, T., Pidsley, R., Troakes, C., Bernstein, H.-G., Kreutz, M.R., Mill, J., Nikolic, M., Giese, K.P., 2011. Schizophrenia is associatedwith dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 134 (8), 2408-2421.
8. Enz, R., 2007. The trick of the tail: protein-protein interactions ofmetabotropic glutamate receptors. Bioessays 29 (1), 60-73.
9. Fernandez-Enright, F., Andrews, J.L., Newell, K.A., Pantelis, C., Huang, X.F., 2014. Novel implications of Lingo-1 and its signaling partners in schizophrenia. Transl. Psychiatry 4 (1), e348.
10. Han, M., Newell, K., Zavitsanou, K., Deng, C., Huang, X.F., 2008. Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain. J. Neurosci. Res. 86 (2), 457-464.
11. Harvey, P., 2013. Cognitive Impairment in Schizophrenia: Characteristics, Assessment and Treatment. illustrated ed. Cambridge University Press, Cambridge.
12. Hu, W., MacDonald, M.L., Elswick, D.E., Sweet, R.A., 2014. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann. N. Y. Acad. Sci. http://dx.doi.org/10.1111/nyas.12547.
13. Jong, Y.-J.I., Sergin, I., Purgert, C.A., O'Malley, K.L., 2014. Location-dependent signaling of the group 1 metabotropic glutamate receptor, mGlu5. Mol. Pharmacol. http://dx.doi.org/10.1124/mol.114.094763.
14. Kitano, J., Kimura, K., Yamazaki, Y., Soda, T., Shigemoto, R., Nakajima, Y., Nakanishi, S., 2002. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins. J. Neurosci. 22 (4), 1280-1289.
15. Kitano, J., Yamazaki, Y., Kimura, K., Masukado, T., Nakajima, Y., Nakanishi, S., 2003. Tamalin is a scaffold protein that interacts withmultiple neuronal proteins in distinct modes of protein-protein association. J. Biol. Chem. 278 (17), 14762-14768.
16. Lu, Y.M., Jia, Z., Janus, C., Henderson, J.T., Gerlai, R., Wojtowicz, J.M., Roder, J.C., 1997. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17 (13), 5196-5205.
17. Manahan-Vaughan, D., Braunewell, K.H., 2005. The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb. Cortex 15 (11), 1703-1713.
18. Matosin, N., Newell, K.A., 2013. Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia. Neurosci. Biobehav. Rev. 37 (3), 256-268.
19. Matosin, N., Frank, E., Deng, C., Huang, X.-F., Newell, K.A., 2013. Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment. Schizophr. Res. 146 (1-3), 170-176.
20. Mukherjee, S., Manahan-Vaughan, D., 2013. Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning. Neuropharmacology 66, 65-81.
21. Ohnuma, T., Tessler, S., Arai, H., Faull, R.L.M., McKenna, P.J., Emson, P.C., 2000. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Mol. Brain Res. 85 (1-2), 24-31.
22. Purgert, C.A., Izumi, Y., Jong, Y.-J.I., Kumar, V., Zorumski, C.F., O'Malley, K.L., 2014. Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus. J. Neurosci. 34 (13), 4589-4598.
23. Spellmann, I., Rujescu, D., Musil, R., Mayr, A., Giegling, I., Genius, J., Zill, P., Dehning, S., Opgen-Rhein, M., Cerovecki, A., Hartmann, A.M., Schäfer, M., Bondy, B., Müller, N., Möller, H.-J., Riedel, M., 2011. Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients. J. Psychiatr. Res. 45 (2), 234-241.
24. Szumlinski, K.K., Kalivas, P.W., Worley, P.F., 2006. Homer proteins: implications for neuropsychiatric disorders. Curr. Opin. Neurobiol. 16 (3), 251-257.
25. Tai, H.-C., Besche, H., Goldberg, A.L., Schuman, E.M., 2010. Characterization of the brain 26S proteasome and its interacting proteins. Front. Mol. Neurosci. 3 (12), 1-19.
26. Timms, A.E., Dorschner, M.O., Wechsler, J., Choi, K.Y., Kirkwood, R., Girirajan, S., Baker, C., Eichler, E.E., Korvatska, O., Roche, K.W., Horwitz, M.S., Tsuang, D.W., 2013. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry Chic. 70 (6), 582-590.
27. Ulloa-Aguirre, A., Conn, P.M., 2011. Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors. Recent Pat. Endocr. Metab. Immune Drug Discov. 5, 13-24.
28. Vrajová, M., Šastnỳ, F., Horácek, J., Lochman, J., Šerỳ, O., Peková, S., Klaschka, J., Höschl, C., 2010. Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem. Res. 35 (7), 994-1002.
29. Wang, H., Westin, L., Nong, Y., Birnbaum, S., Bendor, J., Brismar, H., Nestler, E., Aperia, A., Flajolet, M., Greengard, P., 2009. Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling. Science 326 (5959), 1554-1557.
30. Weston-Green, K., Huang, X.F., Lian, J., Deng, C., 2012. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels. Eur. Neuropsychopharmacol. 22 (5), 364-373.